BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cooper CL, Galanakis C, Donelle J, Kwong J, Boyd R, Boucher L, Kendall CE. HCV-infected individuals have higher prevalence of comorbidity and multimorbidity: a retrospective cohort study. BMC Infect Dis 2019;19:712. [PMID: 31438873 DOI: 10.1186/s12879-019-4315-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Morris KE, Muir AJ. Care After Cure: Long-term Follow-up in Hepatitis C. Curr Hepatology Rep 2021;20:183-190. [DOI: 10.1007/s11901-021-00579-5] [Reference Citation Analysis]
2 Tanaka S, Shinkawa H, Tamori A, Takemura S, Uchida-Kobayashi S, Amano R, Kimura K, Ohira G, Nishio K, Tauchi J, Kinoshita M, Kawada N, Kubo S. Postoperative direct-acting antiviral treatment after liver resection in patients with hepatitis C virus-related hepatocellular carcinoma. Hepatol Res 2021;51:1102-14. [PMID: 34476874 DOI: 10.1111/hepr.13709] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Kim T, Kim J. Factors Associated with Hepatitis C Antibody Positivity in Korean Adults: A Cross-Sectional Study Based on 2013-2018 Korea National Health and Nutrition Examination Survey. Healthcare (Basel) 2021;9:1366. [PMID: 34683045 DOI: 10.3390/healthcare9101366] [Reference Citation Analysis]
4 Evon DM, Lin HS, Fontana RJ, Khalili M, Yim C, Wahed AS, Hoofnagle JH. Liver disease symptoms are associated with higher risk of adverse clinical outcomes: A longitudinal study of North American adults with chronic Hepatitis B. GastroHep 2021;3:196-208. [PMID: 34421369 DOI: 10.1002/ygh2.458] [Reference Citation Analysis]
5 Aghemo A, Horsmans Y, Bourgeois S, Bondin M, Gschwantler M, Hofer H, Semmo N, Negro F, Zhang Z, Marcinak J, Veitsman E, Hazzan R, Mimidis K, Goulis I, Marques N, Flisiak R, Mazur W, Roncero C, Marra F, Pageaux GP, Asselah T, Lampertico P. Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir. Infect Dis Ther 2021. [PMID: 34125405 DOI: 10.1007/s40121-021-00455-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
6 Esaulenko EV, Novak KE, Basina VV, Dzemova AA, Ganchenko RA. Prevalence of comorbidity in chronic HCV‑infection. Medicinskij alfavit 2021. [DOI: 10.33667/2078-5631-2021-1-66-70] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Bai C, Tian H. Subclinical Hepatitis C Virus Infection in Patients with Chronic Obstructive Pulmonary Disease: Evidence from a Cross-Sectional Multicenter Observation Study. Jundishapur J Microbiol 2021;13. [DOI: 10.5812/jjm.109352] [Reference Citation Analysis]
8 Plaksin SA, Farshatova LI. The impact of comorbidities on diagnosis and treatment of pleural effusions of various origins. Pulʹmonologiâ (Mosk ) 2020;30:798-804. [DOI: 10.18093/0869-0189-2020-30-6-798-804] [Reference Citation Analysis]
9 Wang Y, Liang H, Zhang L, Zhang Z, Wu L, Ni L, Gao G, Yang D, Zhao H, Xiao J. The burden of serious non-AIDS-defining events among admitted cART-naive AIDS patients in China: An observational cohort study. PLoS One 2020;15:e0243773. [PMID: 33351812 DOI: 10.1371/journal.pone.0243773] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
10 Pena DZ, Anadão MF, Flores EF, Okada MN, Filho AMP, Ferro RS, Prestes-Carneiro LE. Clinical, Epidemiological, and Geospatial Characteristics of Patients Infected with Hepatitis C Virus Treated with Second-Generation Direct-Action Antivirals in a Reference Center in a Mesoregion of São Paulo State, Brazil. Microorganisms 2020;8:E1575. [PMID: 33066136 DOI: 10.3390/microorganisms8101575] [Reference Citation Analysis]
11 Coyer L, Njoya O, Njouom R, Mossus T, Kowo MP, Essomba F, Boers A, Coutinho R, Ondoa P; HEP C-IMPACT Team. Achieving a high cure rate with direct-acting antivirals for chronic Hepatitis C virus infection in Cameroon: a multi-clinic demonstration project. Trop Med Int Health 2020;25:1098-109. [PMID: 32502290 DOI: 10.1111/tmi.13450] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Gabuzda D, Jamieson BD, Collman RG, Lederman MM, Burdo TH, Deeks SG, Dittmer DP, Fox HS, Funderburg NT, Pahwa SG, Pandrea I, Wilson CC, Hunt PW. Pathogenesis of Aging and Age-related Comorbidities in People with HIV: Highlights from the HIV ACTION Workshop. Pathog Immun 2020;5:143-74. [PMID: 32856008 DOI: 10.20411/pai.v5i1.365] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
13 Kendall CE, Fitzgerald M, Donelle J, Kwong JC, Galanakis C, Boyd R, Cooper CL. A cross-sectional study of prolonged disengagement from clinic among people with HCV receiving care in a low-threshold, multidisciplinary clinic. CanLivJ 2020;3:212-23. [DOI: 10.3138/canlivj.2019-0020] [Reference Citation Analysis]
14 Cooper CL, Galanakis C, Donelle J, Kwong JC, Boyd R, Boucher L, Kendall CE. Correction to: HCV-infected individuals have higher prevalence of comorbidity and multimorbidity: a retrospective cohort study. BMC Infect Dis 2019;19:889. [PMID: 31651290 DOI: 10.1186/s12879-019-4579-x] [Reference Citation Analysis]